VBI VACCINES INC. news, videos and press releases - Page 4
For more news please use our advanced search feature.
VBI VACCINES INC. - More news...
VBI VACCINES INC. - More news...
- VBI Vaccines Announces U.S. FDA Acceptance of BLA Filing for VBI’s 3-Antigen Prophylactic Hepatitis B Vaccine
- VBI Vaccines Inc. - VBIV Stock Chart Technical Analysis for 02-01-2021
- VBI Vaccines Announces Progress of Coronavirus Vaccine Program
- VBI Vaccines Announces Publication of Results from a Phase 4 Study of VBI’s Prophylactic 3-Antigen Hepatitis B Vaccine in Vaccine
- VBI Vaccines Announces European Medicines Agency Acceptance of Marketing Authorization Application (MAA) for 3-Antigen Prophylactic Hepatitis B Vaccine
- VBI Vaccines Selects Syneos Health as Commercialization Partner for Prophylactic 3-Antigen Hepatitis B Vaccine
- VBI Vaccines to Discuss Hepatitis B Portfolio in Virtual Fireside Chat Hosted by Raymond James
- VBI Vaccines Announces Submission of Biologics License Application to FDA for 3-Antigen Prophylactic Hepatitis B Vaccine
- VBI Vaccines Announces Submission of Marketing Authorization Application for 3-Antigen Prophylactic Hepatitis B Vaccine to the European Medicines Agency
- VBI Vaccines Announces Positive Interim Phase 2a Data from VBI-1901 in Recurrent GBM
- VBI Vaccines Announces Positive Interim Phase 1b/2a Data for Hepatitis B Immunotherapeutic in Patients with Chronic Infection
- VBI Vaccines Presents Phase 3 Sci-B-Vac® Data at The Liver Meeting® 2020
- VBI Vaccines Announces e-Poster Presentation at the Society for Neuro-Oncology (SNO) 2020 Virtual Meeting
- VBI Vaccines Announces Third Quarter 2020 Financial Results and Provides Corporate Update
- VBI Vaccines Presents Phase 3 Sci-B-Vac® Data at ID Week 2020™
- VBI Vaccines to Present at the H.C. Wainwright Hepatitis B Virus (HBV) Mini-Conference
- VBI Vaccines Announces e-Poster Presentation at The Liver Meeting® 2020
- VBI Vaccines to Present at Upcoming Scientific Conferences
- VBI Vaccines Announces Biomarker Data From VBI-1901 Phase 1/2a Study in Recurrent GBM Presented at ESMO Virtual Congress 2020
- VBI Vaccines Inc. - VBIV Stock Chart Technical Analysis for 08-31-2020
- VBI Vaccines Presents Phase 3 Sci-B-Vac® Data at EASL 2020
- Thinking about buying stock in UnitedHealth, VBI Vaccines Inc, ADMA Biologics, Qutoutiao, or Lipocine Inc?
- VBI Vaccines Inc. - VBIV Stock Chart Technical Analysis for 08-27-2020
- VBI Vaccines Announces Preclinical Coronavirus Program Data and Selection of Clinical Candidates with Potential as One-Dose Vaccines
- VBI Vaccines Announces Multiple Phase 3 Sci-B-Vac® Abstracts Accepted for Oral and Poster Presentations at EASL 2020
- VBI Vaccines Inc. - VBIV Stock Chart Technical Analysis for 08-18-2020
- VBI Vaccines Inc. - VBIV Stock Chart Technical Analysis for 08-05-2020
- VBI Vaccines Awarded Up to CAD$56 Million Contribution from Canadian Government to Accelerate Coronavirus Vaccine Development
- VBI Vaccines Announces Second Quarter 2020 Financial Results and Provides Corporate Update
- VBI Vaccines Inc. - VBIV Stock Chart Technical Analysis for 07-28-2020